HeartCore Signs 13th Go IPO Contract; HeartCore Expects $500,000 In Initial Fees And $300,000 In Success Fees; Received Warrant To Acquire 3% Of PharmaBio's Stock On Fully Diluted Basis
HeartCore Signs 13th Go IPO Contract; HeartCore Expects $500,000 In Initial Fees And $300,000 In Success Fees; Received Warrant To Acquire 3% Of PharmaBio's Stock On Fully Diluted Basis
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.